Hiroyuki Onoue

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial

Ivo N. van Schaik, Vera Bril, Nan van Geloven et al. · The Lancet Neurology · 2017 · 269 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +11

Genome-wide association study of clinically defined gout identifies multiple risk loci and its association with clinical subtypes

Hirotaka Matsuo, Ken Yamamoto, Hirofumi Nakaoka et al. · Annals of the Rheumatic Diseases · 2015 · 184 citations · Full text

Life Sciences, Genetics, Molecular Genetics +12

Nogo-A and Nogo Receptor Expression in Demyelinating Lesions of Multiple Sclerosis

Jun‐ichi Satoh, Hiroyuki Onoue, Kunimasa Arima et al. · Journal of Neuropathology & Experimental Neurology · 2005 · 135 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

The 14-3-3 Protein Forms a Molecular Complex with Heat Shock Protein Hsp60 and Cellular Prion Protein

Jun‐ichi Satoh, Hiroyuki Onoue, Kunimasa Arima et al. · Journal of Neuropathology & Experimental Neurology · 2005 · 80 citations · Full text

Life Sciences, Molecular Biology, Neuroscience +12

T cell gene expression profiling identifies distinct subgroups of Japanese multiple sclerosis patients

Jun‐ichi Satoh, Megumi Nakanishi, Fumiko Koike et al. · Journal of Neuroimmunology · 2006 · 55 citations

Life Sciences, Immunology, Neurology +16